Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
International Markets
Europe
About Lesley McCuaig
Lesley enjoys spending time with family and friends, skiing, golfing, and photography. When she's not working, she enjoys advocating for mental health issues, particularly those surrounding schizophrenia.
History with the Condition
Lesley was diagnosed with schizophrenia in 2016, but symptoms such as auditory hallucinations began in 2015. Since her diagnosis, she has been a peer supporter for mental health, achieved a Master of Arts in Counseling Psychology, and works as a Clinical Therapist.
When Lesley’s not working, she speaks publicly about living with schizophrenia in hopes of reducing the stigma associated with the illness.
Lesley says:
"I have been living with schizophrenia for 8 years and have been able to fulfill quite a few goals and dreams despite my diagnosis. It's important for people to understand that living well with schizophrenia is possible.”
The information presented is solely for educational purposes, not as specific advice for the evaluation, management, or treatment of any condition.
Articles By Lesley McCuaig
Getting Comfortable Dating with Schizophrenia – Some of My Challenges and Wins
Reflect, Recover, Rebuild: Navigating Relationships after Experiencing Psychosis
The individual(s) who have written and created the content and whose images appear in this article have been paid by Teva Pharmaceuticals for their contributions. This content represents the opinions of the contributor and does not necessarily reflect those of Teva Pharmaceuticals. Similarly, Teva Pharmaceuticals does not review, control, influence, or endorse any content related to the contributor's websites or social media networks. This content is intended for informational and educational purposes and should not be considered medical advice or recommendations. Consult a qualified medical professional for diagnosis and before beginning or changing any treatment regimen.
NPS-ALL-NP-01301 JUNE 2024
